These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8700140)

  • 1. Tienilic acid-induced autoimmune hepatitis: anti-liver and-kidney microsomal type 2 autoantibodies recognize a three-site conformational epitope on cytochrome P4502C9.
    Lecoeur S; André C; Beaune PH
    Mol Pharmacol; 1996 Aug; 50(2):326-33. PubMed ID: 8700140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human hepatitis anti-liver kidney microsomes (LKM2) autoantibodies on rat liver sections is predominantly due to reactivity with rat liver P-450 IIC11.
    Pons C; Dansette PM; Amar C; Jaouen M; Wolf CR; Gregeois J; Homberg JC; Mansuy D
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1328-34. PubMed ID: 1762080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis.
    Belloc C; Gauffre A; André C; Beaune PH
    Pharmacogenetics; 1997 Jun; 7(3):181-6. PubMed ID: 9241657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.
    Lytton SD; Berg U; Nemeth A; Ingelman-Sundberg M
    Clin Exp Immunol; 2002 Feb; 127(2):293-302. PubMed ID: 11876753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite behaviors of reactive metabolites of tienilic acid and its isomer toward liver proteins: use of specific anti-tienilic acid-protein adduct antibodies and the possible relationship with different hepatotoxic effects of the two compounds.
    Bonierbale E; Valadon P; Pons C; Desfosses B; Dansette PM; Mansuy D
    Chem Res Toxicol; 1999 Mar; 12(3):286-96. PubMed ID: 10077492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug.
    Beaune P; Dansette PM; Mansuy D; Kiffel L; Finck M; Amar C; Leroux JP; Homberg JC
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):551-5. PubMed ID: 3540968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.
    Robin MA; Maratrat M; Le Roy M; Le Breton FP; Bonierbale E; Dansette P; Ballet F; Mansuy D; Pessayre D
    J Clin Invest; 1996 Sep; 98(6):1471-80. PubMed ID: 8823314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.
    Lecoeur S; Bonierbale E; Challine D; Gautier JC; Valadon P; Dansette PM; Catinot R; Ballet F; Mansuy D; Beaune PH
    Chem Res Toxicol; 1994; 7(3):434-42. PubMed ID: 8075377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
    Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
    Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acid derivatives and molecular modeling.
    Mancy A; Broto P; Dijols S; Dansette PM; Mansuy D
    Biochemistry; 1995 Aug; 34(33):10365-75. PubMed ID: 7654690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
    Obermayer-Straub P; Strassburg CP; Manns MP
    Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
    Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
    Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1).
    Yamamoto AM; Cresteil D; Boniface O; Clerc FF; Alvarez F
    Eur J Immunol; 1993 May; 23(5):1105-11. PubMed ID: 7682958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
    Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
    J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.
    Homberg JC; Andre C; Abuaf N
    Clin Exp Immunol; 1984 Mar; 55(3):561-70. PubMed ID: 6368059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
    Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cytochrome P450 autoantibodies in drug-induced disease.
    Beaune PH; Lecoeur S; Bourdi M; Gauffre A; Belloc C; Dansette P; Mansuy D
    Eur J Haematol Suppl; 1996; 60():89-92. PubMed ID: 8987248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune mechanisms in tienilic acid associated hepatotoxicity.
    Neuberger J; Williams R
    Gut; 1989 Apr; 30(4):515-9. PubMed ID: 2714684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.